Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 6.62 Delayed Data As of Jun 24 |  -0.07 / -1.05%Today’s Change | 4.81 Today|||52-Week Range 8.65 | -2.22% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 500.0K | 12.4M | 28.8M | |
| Cost of Goods Sold | 0.00 | -- | 1.7M | 4.3M | ||
| Depreciation And Amortization | 9.3K | 12.5K | 13.7K | 6.4K | ||
| Operating Expenses | Gross Income | -9.3K | -- | 10.7M | 24.6M | |
| General Expenses | 8.2M | 15.3M | 11.7M | 13.6M | ||
| Research And Development | 4.5M | 8.4M | 3.3M | 4.6M | ||
| Total Operating Expenses | 8.2M | 15.3M | 13.4M | 17.9M | ||
| Non-Operating Expenses | Operating Income | -8.2M | -14.8M | -987.8K | 11.0M | |
| Extraordinary Credit | 0.00 | 0.00 | 52.7K | 36.7K | ||
| Other Expenses | 343.7K | 343.7K | 290.5K | 413.8K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -7.8M | -14.5M | -644.5K | 11.4M | |
| Income Taxes | 0.00 | 0.00 | 0.00 | -449.7K | ||
| Net Income | -7.8M | -14.5M | -644.5K | 11.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 102.6M | 102.7M | 102.7M | 102.9M | |
| Shares To Calculate EPS Diluted | 102.6M | 102.7M | 102.7M | 105.9M | ||
| Earnings Per Share | EPS | -$0.08 | -$0.14 | -$0.01 | $0.10 | |
| EPS Diluted | -$0.08 | -$0.14 | -$0.01 | $0.10 | ||
